What do the upcoming trends in medical devices look like? In the fast-changing healthcare sector, keeping up-to-date with the newest developments in medical technology is crucial for experts and enthusiasts. Medical Device News Magazine is a crucial source of information, providing valuable perspectives on state-of-the-art innovations, regulatory changes, FDA updates on medical devices, and industry trends affecting patient care and business approaches. Our goal is to connect healthcare professionals, investors, and the medical device industry by offering breaking medical device news and articles authored by experts in this space. Medical Device News Magazine aims to stimulate discussions on advancements in medical devices and biotechnology, and their impact on the future of medicine.
Submission based on positive data from two pivotal studies, which both met their primary endpoints. U.S. clearance expected in Q3 2025 based on average observed review timelines for radiological medical devices.
CPR Therapeutics Inc. is an early-stage start-up supported by funding from the NSF and NIH
This collaboration aims to extract and validate a range of AI-based quantitative CT (QCT) measures, identifying imaging biomarkers that hold the greatest potential for improving COPD phenotyping and advancing precision care.
Imagine what modern medicine would be like without the ability to effectively and consistently administer drugs intravenously. That’s a good way to frame the huge delivery limitation that plagues neuroscience: Despite all the advances in drug discovery over the past decades, the biggest roadblock to treating brain cancers and other neurological diseases and disorders remains the brain’s own protective shield, the blood-brain barrier. Read on.
“Liquid biopsy is a revolutionary, non-invasive method for detecting diseases like cancer through blood samples instead of traditional tissue biopsies. This market is rapidly growing, offering advanced tools, services, and diagnostics that improve early detection, monitoring, and treatment decisions worldwide.”
A new 2025 Global Trauma Devices Market Report reveals critical insights for orthopedic device executives, product strategists, and investors seeking to navigate pricing pressures, material innovations, and shifting surgical practices in the orthopedic trauma sector.
“Our study shows that widely used large language models have the potential to transform patient education materials into more readable content, which is essential for patient empowerment and better health outcomes,” said Study senior author Jonah Feldman, MD, medical director of transformation and informatics at NYU Langone.
Trial achieves positive results in the treatment of persistent atrial fibrillation.
In vivo studies demonstrated the pump’s successful operation for a period of up to six months. Additionally, nine chronic ovine implants were conducted for 60 days with no device failure or sign of thrombosis at explant. These significant milestones mark the final stage of CorWave’s preclinical development, paving the way for its First-In-Human study.
Caliway has completed the End-of-Phase 2 (EOP2) meeting with the U.S. FDA for CBL-514, the world’s first investigational drug for large-area subcutaneous fat reduction developed under the 505(b)(1) regulatory pathway.
The EIC Soft-landing Programme provides business development support and opportunities to connect with investors, academic institutions and life science stakeholders in Boston – a global hub for cancer research and biotechnology. Neogap’s combination of AI, bioinformatics and cell biology in developing personalised immunotherapy aligns well with the programme’s focus on deep tech companies.
BD SpectralFXâ„¢ Technology maximizes the number of colors that can be used in flow cytometry, allowing scientists to analyze up to 50 or more characteristics of a single cell at one time, with optimal resolution and sensitivity, which is ideal for scientists pursuing novel biomarker discovery.
The investment is aimed at supporting the company’s strategy to deliver its platform and product suite to global pharma companies through a SaaS model, while continuing to invest in further offerings within the Dawn Product Suite.
Oramed leverages its strategic capital markets expertise to support Alpha Tau’s breakthrough cancer therapy technology
The round was led by Cowles Ventures, TVF Funds, Inland Imaging Investments, KickStart Funds, and prominent angel investors from the Pacific Northwest.
Executives On The Move
Appoints Professor Nada Jabado and Professor Burkhard Becher to its scientific advisory board.
With more than two decades of finance and accounting expertise, Dalen brings extensive experience in scaling private and public companies to his new role.
Dan Cummings will be responsible for Precision AQ’s commercial and go-to-market strategies, with the goal of bringing Precision AQ’s comprehensive suite of capabilities to help biopharmaceutical companies advance life-changing therapies to market.
Brennan will transition out of the chief financial officer position at the end of June and is expected to remain with Boston Scientific as a senior advisor through early October 2025.
DREAM OCT is able to cover an ultrawide field single scan which delivers a 130° OCTA image. DREAM OCT™ swept-source 12 mm super-depth scanning allows superior imaging of the choroid and retina, and a large portion of the vitreous space.
Medical diagnostics is undergoing a rapid transformation, and United Imaging is at the forefront of this change. Through a combination of advanced technology, artificial intelligence and thoughtful equipment design, the company is redefining the standards of modern healthcare.
This strategic move underscores the Sun Nuclear commitment to leverage cutting-edge technology to improve treatment outcomes on behalf of their customers.
“Renal denervation for hypertension is an exciting medical advancement for the millions of patients it may help and is supported by positive results from contemporary clinical trials and ongoing research,” said Lance Bates, senior vice president and president, Interventional Cardiology Therapies, Boston Scientific. “We believe the addition of the differentiated, ultrasound-based TIVUS system can complement our expansive interventional portfolio with a minimally invasive therapy for patients with hypertension and provides opportunity for future advancements in this space.”
Da Vinci 5 is the newest entry to the da Vinci portfolio of systems, which also includes da Vinci X®, da Vinci Xi®, and da Vinci SP®. The system can be used for minimally invasive surgical procedures for urology, gynecology, thoracic, and general surgeries.
The Business of Healthcare
EMR systems enable mental health professionals to maintain and access patient records with ease, creating a more efficient workflow and better patient outcomes.
Tips for Healthcare Professionals
Positive and negative online reviews can be managed in various ways. In this article, we’ll explore how doctors manage their online reputation and learn how to respond to negative patient reviews.
Healthcare Careers
Learn about the vital role of Psychiatric-Mental Health Nurse Practitioners (PMHNPs) in modern healthcare.
Abbreviated breast MRI shortens exam time while retaining a high level of diagnostic accuracy of breast cancer in women with extremely dense breasts, according to
Marianne Cracchiolo Mago, CEO of The Steele Foundation: “My father’s name representing the fight to cure pediatric diseases is a momentous opportunity. This cements his legacy and represents a significant moment for our family and the foundation.”
Veronica Barcelona, PhD, an assistant professor at Columbia Nursing, and her colleagues also found differences in how Hispanic and Asian/Pacific Islander (API) patients were described compared to White patients.
The finalists for the fourth edition of the awards were selected from a pool of 100,000+ registrations received from 199* countries worldwide.
Copyright 2025 | All Rights Reserved | Medical Device News Magazine, is a Division of PTM Healthcare Marketing, Inc.
